Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + ropivacaine vs ropivacaine alone for pediatric ultrasound-guided brachial plexus block
ChiCTR2100045358Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and ropivacaine in pain, postoperative pain and procedural pain (4 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Duration of sensory block. Started Apr 2021; status: recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
painpostoperative painprocedural pain
Beyond the preview
Go deeper on ChiCTR2100045358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045358.